scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Ding Wen Chen | Q88176547 |
Marianna Foldvari | Q88176551 | ||
P2093 | author name string | Ding Wen Chen | |
Marianna Foldvari | |||
P2860 | cites work | Comparative analysis of DNA nanoparticles and AAVs for ocular gene delivery | Q27325842 |
Subtype-specific regeneration of retinal ganglion cells following axotomy: effects of osteopontin and mTOR signaling | Q30360159 | ||
Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. | Q33193314 | ||
Combined application of BDNF to the eye and brain enhances ganglion cell survival and function in the cat after optic nerve injury | Q33847477 | ||
Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells | Q36014895 | ||
Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina | Q37195549 | ||
Differential progression of structural and functional alterations in distinct retinal ganglion cell types in a mouse model of glaucoma | Q37266516 | ||
Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models | Q37393418 | ||
Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma | Q38030642 | ||
A forensic path to RGC-5 cell line identification: lessons learned | Q38131460 | ||
The types of retinal ganglion cells: current status and implications for neuronal classification | Q38432885 | ||
Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier | Q38569775 | ||
The role of lamina cribrosa cells in optic nerve head fibrosis in glaucoma | Q38671315 | ||
Neural stem cell-based intraocular administration of ciliary neurotrophic factor attenuates the loss of axotomized ganglion cells in adult mice | Q38951804 | ||
Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brain. | Q40451780 | ||
Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: towards non-invasive glaucoma gene therapy. | Q42213993 | ||
Long-term rescue of rat retinal ganglion cells and visual function by AAV-mediated BDNF expression after acute elevation of intraocular pressure | Q48712058 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | gene therapy | Q213901 |
retinal ganglion cell | Q927337 | ||
nervous system development | Q1345738 | ||
P304 | page(s) | 875-877 | |
P577 | publication date | 2016-06-01 | |
P1433 | published in | Neural Regeneration Research | Q15710164 |
P1476 | title | The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy | |
P478 | volume | 11 |
Q57818175 | Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection |
Q37615060 | Regulation of Stem Cell Properties of Müller Glia by JAK/STAT and MAPK Signaling in the Mammalian Retina |
Q93103187 | Target-Derived Neurotrophic Factor Deprivation Puts Retinal Ganglion Cells on Death Row: Cold Hard Evidence and Caveats |